Navigation Links
HeartSine® Technologies Named One of the Most Innovative Businesses in the United Kingdom
Date:9/6/2011

NEWTOWN, Pa., Sept. 6, 2011 /PRNewswire/ -- HeartSine® Technologies, Inc., a world leader in personal and public access defibrillators, announced that it is a finalist to receive the coveted Orange Innovation Award in the 10th annual UK National Business Awards. HeartSine was selected because of its innovative approach to the design, development and manufacture of Automated External Defibrillators (AED) for the treatment of Sudden Cardiac Arrest.

The Orange Innovation Award recognizes businesses that have gone beyond the ordinary in their development and who have implemented cutting edge innovation in terms of products, services or company culture. The clinically advanced technology within HeartSine's leading edge cardiac defibrillation products enables the company to compete successfully in the global healthcare market.

HeartSine's Public Access Defibrillator (PAD) devices meet and exceed AED clinical efficacy standards. This innovation enables HeartSine to provide its global customers with exceptional product reliability, the lowest cost of ownership and superior technology that helps save lives.

"Our long history of invention and innovation in the AED industry continues today in our ongoing commitment to developing and providing the highest level of clinically advanced, lifesaving technology to customers around the globe," said Marc Lawrence, senior vice president, HeartSine. "We are honored to have been selected as a finalist for this prestigious award."

HeartSine will prepare a presentation in person before an independent panel of experts in October. Winners will be announced in November at an awards ceremony in London.  

About HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care. HeartSine® samaritan® PAD (Public Access Defibrillator) is the only medical device specifically designed for public access use to administer lifesaving treatment for Sudden Cardiac Arrest. It's lifesaving, pure and simple.

For more information, please contact info@heartsine.com, call (866) 478-7463, ext. 112, or visit www.heartsine.com.

Download a high-res photo of the samaritan® PAD 300P: http://www.ggcomm.com/HeartSine/PAD300P.jpg

121 Friends Lane
Suite 400
Newtown, PA 18940
Phone: 215.860.8100 ext. 112
Contact: Stacey Lock
stacey.lock@heartsine.com


'/>"/>
SOURCE HeartSine Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Shock for Life and HeartSine® Technologies Now Exclusive Providers of Lifesaving AED Solution to Wegmans Food Markets
2. HeartSine® Technologies Donates Lifesaving AED to Camphill Special School
3. HeartSine® Increases AED System Warranty to Longest in the Industry
4. Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
5. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ
6. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
7. China Medical Technologies Reports First Fiscal Quarter Financial Results
8. Patient Safety Technologies Reports Second Quarter 2011 Results
9. Deloitte Stakes Claim in Drug Safety & Regulatory Consulting Market With Acquisition of Intrasphere Technologies, Inc. Assets
10. Althea Technologies Hosts Health and Wellness Week
11. China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... June 8, 2017   Responding to Heath Ledger,s ... the death of singer Chris Cornell in May, ... International offers a free online psychiatric drug ... and families about psychotropic drug risks. The ... died from an accidental overdose, has called for tighter rules ...
(Date:6/7/2017)... Md. , June 7, 2017  Novavax, Inc., (Nasdaq: ... second of two Phase 2 trials of its RSV F ... of child bearing age have been published in the journal ... publication have been shared in prior scientific conferences). The Company ... in April 2014. Novavax is developing the RSV F Vaccine ...
(Date:6/5/2017)... , June 5, 2017 Kohll,s Pharmacy & Homecare is ... the United States . The Raizer is a ... fallen person up to an almost-standing position within ... operated by one assistant and does not require ... enough that a child can operate it, and ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... 20, 2017 , ... AMC Health , the leading provider of proven ... trials market. Similar to its approach in demonstrating positive outcomes in the healthcare market, ... proving the value of eVisits to support virtual studies. , In a ...
(Date:6/20/2017)... ... June 20, 2017 , ... With certifications and experience that puts ... NJ, Drs. Adam and Hal Kimowitz are currently accepting new patients at their practice ... can cause for some patients, which is why they offer the latest in modern ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage (UA), a multi-channel retailer ... designed to create tailored looks and athleisure-inspired outfits. UA Flex fabric is breathable, wrinkle ... twill. , With trendy looks hitting the medical community, UA Flex is for the ...
(Date:6/20/2017)... ... 20, 2017 , ... MEDI+SIGN, a healthcare technology company that ... Stanowski, DHA, FACHE to the MEDI+SIGN Advisory Board. , “We are eager ... provide invaluable direction for the company,” says Andrew Hoffman, President of MEDI+SIGN. ...
(Date:6/19/2017)... ... June 19, 2017 , ... The joyful summer wedding ... to be a humdinger. A warm winter and wet spring have created ideal conditions ... one wants to be swatting away pesky mosquitoes when a bride and groom are ...
Breaking Medicine News(10 mins):